Plain-English translation of NCT07209033 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study compares a new bone graft material called FlexiOss® to the standard bone graft treatment currently used for people who have suffered traumatic bone injuries. Researchers want to see if FlexiOss® works as well as — or better than — the traditional approach at helping bones heal and regain function. The study will follow participants for up to 2 years to track how well the new material performs.
Current bone graft treatments work, but doctors are looking for materials that might heal bones faster, safer, or more effectively. This trial will help determine if the new treatment offers real advantages for patients with serious bone injuries.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive either the new FlexiOss® bone graft material or the standard bone graft treatment during your orthopedic surgery. After surgery, you will attend follow-up visits at 2 weeks, 6 weeks, 3 months, 6 months, 12 months, and 24 months to allow doctors to check how well your bone is healing using imaging scans and clinical exams. The study team will monitor your progress and ensure your recovery is on track throughout the 2-year period.
AI-generated summary from trial data · Sep 24, 2026 · Not medical advice
Poland